GLUE — Monte Rosa Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Monte Rosa Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	346	263	232	372	377
Net Total Accounts Receivable
Net Total Receivables	—	7.66	0.505	0.173	11.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	349	276	236	377	393
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.3	61.9	62.6	56.3	50.4
Other Long Term Assets
Total Assets	366	342	304	439	449
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.6	25.6	46.6	157	64.2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	18.8	71	125	216	216
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	348	271	179	223	233
Total Liabilities & Shareholders' Equity	366	342	304	439	449
Total Common Shares Outstanding